(Q44447734)

English

Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease

scientific article published in November 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

Alexander CM

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Landsman PB

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Teutsch SM

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 November 2000

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

86

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

897-902

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Prevalence of type 2 diabetes mellitus and risk of hypertension and coronary artery disease in rural and urban population with low rates of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Racial and ethnic differences in glycemic control of adults with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Lipids and lipoproteins as risk factors for coronary heart disease in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Treatment of diabetic dyslipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Diabetic dyslipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Management of dyslipidemia in adults with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Pathophysiology of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Low-density and high-density lipoprotein subspecies and risk for premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Impact of multiple risk factor profiles on determining cardiovascular disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Hypertension and macrovascular disease--the killing fields of NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Impaired glucose tolerance and the likelihood of nonfatal stroke and myocardial infarction: the Third National Health and Nutrition Examination Survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Is there a glycemic threshold for mortality risk?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901118-8

7 January 2021

Identifiers

10.1016/S0002-9149(00)01118-8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44447734&oldid=2024465641"